Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vertebral endplate is a complex anatomical interface consisting of a cartilaginous layer and a subchondral bone layer that separates the vertebral body from the intervertebral disc (Source: StatPearls, NBK441915). Its primary biological function is to act as a semi-permeable barrier that facilitates the transport of essential nutrients like glucose and oxygen to the disc cells while allowing metabolic waste to exit (Source: PubMed, PMID: 15507787). Additionally, it plays a vital role in mechanical load distribution, protecting the disc from excessive pressure and maintaining spinal stability (Source: NIH, PMC3621213). In disease states such as intervertebral disc degeneration (IDD), the endplate often undergoes calcification or structural damage, which impairs nutrient flow and leads to disc dehydration and cell death (Source: PubMed, PMID: 23459133). Inflammatory changes within this environment, known as Modic changes, are strongly correlated with chronic low back pain and accelerated spinal aging (Source: PubMed, PMID: 18287995). Although not a single molecular target, the cellular environment of the endplate—including osteoblasts and chondrocytes—is targeted by bone-active drugs like bisphosphonates and growth factors to improve disc health (Source: PubMed, PMID: 27117192). Therapeutic interventions aim to maintain the porosity of the endplate and suppress local inflammation to halt the progression of degenerative spinal diseases (Source: PubMed, PMID: 30321454).
Modulation of bone turnover and maintenance of endplate permeability to ensure nutrient supply to the intervertebral disc.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vertebral endplate (VEP).